Duration of nuclear NF-kappaB action regulated by reversible acetylation.  [electronic resource] 

 -  Science (New York, N.Y.)  Aug 2001 
 - 1653-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0036-8075 
<br/><br/><label>Standard No.: </label>10.1126/science.1062374  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Acetyltransferases--metabolism<br/>Active Transport, Cell Nucleus<br/>Animals<br/>COS Cells<br/>CREB-Binding Protein<br/>Cell Cycle Proteins--metabolism<br/>Cell Line<br/>Cell Nucleus--metabolism<br/>Cytoplasm--metabolism<br/>DNA--metabolism<br/>DNA-Binding Proteins--metabolism<br/>HeLa Cells<br/>Histone Acetyltransferases<br/>Histone Deacetylase Inhibitors<br/>Histone Deacetylases--metabolism<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>I-kappa B Proteins<br/>Mice<br/>NF-KappaB Inhibitor alpha<br/>NF-kappa B--metabolism<br/>Nuclear Proteins--metabolism<br/>Phosphorylation<br/>Protein Binding<br/>Protein Transport<br/>Recombinant Fusion Proteins--metabolism<br/>Trans-Activators--metabolism<br/>Transcription Factor RelA<br/>Transcription Factors<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>p300-CBP Transcription Factors